Dactolisib not checked

Restorbio Inc. · RTB101 · BEZ235

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
1 active
3 in total
Targets
 

What this is

How it works
Blocks PI3K, an enzyme that passes growth signals inside cells. Mostly used against cancer.-lisib: PI3K inhibitors WHO name stem
How it’s given
“Oral RTB101 10 mg hard gelatin capsule once daily for 2 weeks”In the company’s words, NCT04584710 on ClinicalTrials.gov
Tested for
Covid19
Main trialPhase 2
“The proposed trial will obtain preliminary data on the feasibility of studying RTB101 as compared to placebo for COVID-19 post-exposure prophylaxis in adults age ≥ 65 years to inform the design of a subsequent pivotal trial.”In the company’s words, NCT04584710 on ClinicalTrials.gov
Other names
RTB101 · BEZ235

Other drugs for Covid19

All 43 drugs for Covid19

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 2Active, not recruiting Feb 2021 A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults
Phase 3Completed 2 Dec 2019 A Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in the Elderly
Phase 2Terminated 27 Dec 2020 Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Dactolisib

Following is part of Solo: you see every change to Dactolisib the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in